Future drug discovery in renin-angiotensin-aldosterone system intervention.

about

N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output.Novel F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System

P2860

Q52593609-C3B3009D-5D85-47F2-9D9E-D13D7894651A Q57063523-0F6BBD56-CFD9-4598-9793-204C848693D7

P2860

Future drug discovery in renin-angiotensin-aldosterone system intervention.

Item

http://www.wikidata.org/entity/Q38679303

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Future drug discovery in renin-angiotensin-aldosterone system intervention.

@en

type

Item

label

Future drug discovery in renin-angiotensin-aldosterone system intervention.

@en

prefLabel

Future drug discovery in renin-angiotensin-aldosterone system intervention.

@en

P1476

Future drug discovery in renin-angiotensin-aldosterone system intervention.

@en

P2093

Juan Tamargo

http://www.w3.org/2001/XMLSchema#string

Maria Tamargo

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

ACE2 gene expression is up-regulated in the human failing heart

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives

Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

Aldosterone synthase inhibition in humans

Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors

P304

827-848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17460441.2017.1335301

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28541811

http://www.w3.org/2001/XMLSchema#string

Future drug discovery in renin-angiotensin-aldosterone system intervention.

about

P2860

P2860

Future drug discovery in renin-angiotensin-aldosterone system intervention.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698